CARMEN MARINA MESEGUER BARROS

Dr. CARMEN MARINA MESEGUER BARROS

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Preventive Medicine
Verified
Journal Article
Closed access
IGIñaki Galán
Iñaki Galán
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
RHRafael Herruzo
Rafael Herruzo
FRFernando Rodríguez-Artalejo
Fernando Rodríguez-Artalejo

1 October 2009 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
IGIñaki Galán
Iñaki Galán
RHRafael Herruzo
Rafael Herruzo
BZBelén Zorrilla
Belén Zorrilla
FRFernando Rodríguez-Artalejo
Fernando Rodríguez-Artalejo

19 December 2020 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
PDF file
RFRocío Fernández‐Urrusuno
Rocío Fernández‐Urrusuno
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
SASonia Anaya‐Ordóñez
Sonia Anaya‐Ordóñez
YIYolanda Borrego Izquierdo
Yolanda Borrego Izquierdo
MLMaría Jesús Lallana‐Álvarez
María Jesús Lallana‐Álvarez
TTthe Infectious Diseases SEFAP team
the Infectious Diseases SEFAP team
Some patients in the community receive a high burden of antibiotics. We aimed at describing the characteristics of these patients, antibiotics used, and conditions for which they received antibiotics. We carried out a cross‐sectional study. Setting: Thirty Health Primary Care Areas from 12 regions in Spain, covering 5,960,191 inhabitants. Patients having at least 30 packages of antibacterials for systemic use dispensed in 2017 were considered. Main outcome measures: Prevalence of antibiotic use, conditions for which antibiotics were prescribed, clinical characteristics of patients, comorbidities, concomitant treatments, and microbiological isolates. Patient’s average age was 70 years; 52% were men; 60% smokers/ex‐smokers; 54% obese. Overall, 93% of patients had, at least, one chronic condition, and four comorbidities on average. Most common comorbidities were cardiovascular and/or hypertension (67%), respiratory diseases (62%), neurological/mental conditions (32%), diabetes (23%), and urological diseases (21%); 29% were immunosuppressed, 10% were dead at the time of data collection. Patients received three antibiotic treatments per year, mainly fluoroquinolones (28%), macrolides (21%), penicillins (19%), or cephalosporins (12%). Most frequently treated conditions were lower respiratory tract (infections or prophylaxis) (48%), urinary (27%), and skin/soft tissue infections (11%). Thirty‐five percent have been guided by a microbiological diagnosis, being Pseudomonas aeruginosa (30%) and Escherichia coli (16%) the most frequent isolates. In conclusion, high antibiotic consumers in the community were basically elder, with multimorbidity and polymedication. They frequently received broad‐spectrum antibiotics for long periods of time. The approach to infections in high consumers should be differentiated from healthy patients receiving antibiotics occasionally.

28 December 2010 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
IGIñaki Galán
Iñaki Galán
RHRafael Herruzo
Rafael Herruzo
FRFernando Rodríguez-Artalejo
Fernando Rodríguez-Artalejo

15 May 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RFRocío Fernández‐Urrusuno
Rocío Fernández‐Urrusuno
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
RCRegina Sandra Benavente Cantalejo
Regina Sandra Benavente Cantalejo
EHElena Hevia
Elena Hevia
CMCarmen Serrano Martino
Carmen Serrano Martino
BPBeatriz Pascual De La Pisa
Beatriz Pascual De La Pisa
Most effective strategies designed to improve antimicrobial prescribing have multiple approaches. We assessed the impact of the implementation of a rigorous antimicrobial guide and subsequent multifaceted interventions aimed at improving antimicrobial use in Primary Care. A quasi-experimental study was designed. Interventions aimed at achieving a good implementation of the guide consisted of the development of electronic decision support tools, local training meetings, regional workshops, conferences, targets for rates of antibiotic prescribing linked to financial incentives, feedback on antibiotic prescribing, and the implementation of a structured educational antimicrobial stewardship program. Interventions started in 2011, and continued until 2018. Outcomes: rates of antibiotics use, calculated into defined daily doses per 1,000 inhabitants-day (DID). An interrupted time-series analysis was conducted. The study ran from January 2004 until December 2018. Overall annual antibiotic prescribing rates showed increasing trends in the pre-intervention period. Interventions were followed by significant changes on trends with a decline over time in antibiotic prescribing. Overall antibiotic rates dropped by 28% in the Aljarafe Area and 22% in Andalusia between 2011 and 2018, at rates of -0.90 DID per year (95%CI:-1.05 to -0.75) in Aljarafe, and -0.78 DID (95%CI:-0.95 to -0.60) in Andalusia. Reductions occurred at the expense of the strong decline of penicillins use (33% in Aljarafe, 25% in Andalusia), and more precisely, amoxicillin clavulanate, whose prescription plummeted by around 50%. Quinolones rates decreased before interventions, and continued to decline following interventions with more pronounced downward trends. Decreasing cephalosporins trends continued to decline, at a lesser extent, following interventions in Andalusia. Trends of macrolides rates went from a downward trend to an upward trend from 2011 to 2018. Multifaceted interventions following the delivering of a rigorous antimicrobial guide, maintained in long-term, with strong institutional support, could led to sustained reductions in antibiotic prescribing in Primary Care.

1 November 2004 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
Francisco J. De AbajoFrancisco J. De Abajo
Francisco J. De Abajo
CBCARMEN MARINA MESEGUER BARROS
CARMEN MARINA MESEGUER BARROS
GGGuillermo Antiñolo Gil
Guillermo Antiñolo Gil
LRLuis A. García Rodríguez
Luis A. García Rodríguez
DMDolores Montero
Dolores Montero
JTJaume Torelló
Jaume Torelló